Cardinal health details momentum and updated long-term value creation plans at investor day
Key announcements: raising fy25 non-gaap diluted eps guidance to $8.15 to $8.20 1 establishing preliminary fy26 non-gaap diluted eps guidance of $9.10 to $9.30 (13% growth at the mid-points)2 confirming long-term target of 12% to 14% non-gaap diluted eps cagr for fy26 to fy283 raising long-term target for pharmaceutical and specialty solutions profit to 5% to 7% normalized growth3,4 raising long-term target for other profit to ~10% normalized growth3,4,5 updating gmpd long-term target to $50m+ of profit growth per year after fy26 expecting at least $10b in total adjusted free cash flow over next three years raising baseline share repurchase plans to at least $750m per year company reiterating strategic priorities and providing updates across its businesses dublin, ohio , june 12, 2025 /prnewswire/ -- cardinal health (nyse: cah) today will host an investor day beginning at 9:00 a.m. et, where management will detail its growth strategies to maximize the company's potential for all stakeholders.
CAH Ratings Summary
CAH Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission